证券代码：301212 证券简称：联盛化学 公告编号：2024-042 浙江联盛化学股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司（以下简称"公司"或"本公司"）于 2024 年 12 月 25 日召开第三届董事会第十六次会议审议通过了《关于召开 2025 年第一 次临时股东大会的议案》，根据《中华人民共和国公司法》《中华人民共和国证 券法》《深圳证券交易所创业板股票上市规则》等有关法律法规及《公司章程》 的相关规定，公司董事会决定于 2025 年 1 月 14 日召开 2025 年第一次临时股东 大会，现将有关事项通知如下： 一、会议召开基本情况 1、股东大会届次：2025 年第一次临时股东大会 2、召集人：浙江联盛化学股份有限公司董事会 3、合法、合规性：本次股东大会的召集及召开符合相关法律、行政法规、 部门规章、规范性文件、深圳证券交易所相关规则以及《公司章程》的有关规定。 4、会议召开日期、时间： （1）现场会议时间：2025 年 1 月 14 日下午 14:30 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-039 浙江联盛化学股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步优化公司治理结构，提高董事会运作效率，浙江联盛化学股份有限 公司（以下简称"公司"）于 2024 年 12 月 25 日召开第三届董事会第十六次会 议审议通过了《关于调整董事会成员人数暨修订<公司章程>的议案》。公司拟将 董事会成员人数由 8 人调整为 9 人，其中独立董事 3 人，鉴于公司董事会人员的 变更，根据《中华人民共和国公司法》《上市公司章程指引》等相关规定，结合 公司实际，现拟对《浙江联盛化学股份有限公司章程》（以下简称"《公司章程》"） 的相关条款进行修订，具体修订情况如下： | 序号 | 修订前公司章程内容（2024 年 4 月） | 修订后公司章程内容 | | --- | --- | --- | | 1 | 第一百〇六条 董事会由 8 名董事组成，其中 | 第一百〇六条 董事会由 9 名董事组成，其中 | | | 独立董事 3 名。 | 独立董事 3 名。 | 除上述修订条款外，《公司章程》 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-036 浙江联盛化学股份有限公司 关于变更持续督导保荐代表人的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 公司董事会对张锋先生在公司首次公开发行股票并在创业板上市以及持续 督导期间所做的贡献表示衷心的感谢！ 特此公告。 浙江联盛化学股份有限公司 董事会 浙江联盛化学股份有限公司（以下简称"公司"）首次公开发行股票并在创 业板上市的保荐机构为国金证券股份有限公司（以下简称"国金证券"），原委 派聂敏先生、张锋先生作为公司的保荐代表人，负责公司的保荐工作及持续督导 工作，持续督导期至 2025 年 12 月 31 日止。若前述期限届满后公司募集资金尚 未使用完毕，国金证券就相关事项继续履行持续督导义务。 公司于近日收到国金证券出具的《关于变更浙江联盛化学股份有限公司持续 督导保荐代表人的函》。因张锋先生工作变动，不再继续担任公司首次公开发行 股票并在创业板上市的持续督导保荐代表人。为保证公司持续督导工作的有序推 进，国金证券现委派保荐代表人江祥先生（简历详见附件）接替张锋先生的工作， 担任公 ...

国金证券股份有限公司关于浙江联盛化学股份有限公司 拟使用募集资金向全资子公司增资以实施募投项目的核查意见 国金证券股份有限公司（以下简称"国金证券"或"保荐人"）作为浙江联 盛化学股份有限公司（以下简称"联盛化学"或"公司"）首次公开发行股票并 在创业板上市持续督导阶段的保荐人，根据《证券发行上市保荐业务管理办法》 《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》及《深圳证券交易所上市公司自律监管指引 第 13 号——保荐业务》等有关规定，对联盛化学拟使用募集资金向全资子公司 增资以实施募投项目进行了核查，具体情况如下： 一、募集资金基本情况 经中国证券监督管理委员会于 2022 年 2 月 28 日发布的《关于同意浙江联盛 化学股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕413 号）， 同意公司首次公开发行人民币普通股（A 股）股票 2,700 万股，每股面值 1 元， 发行价格为每股人民币 29.67 元，募集资金总额为人民币 80,109.00 万元，扣 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-034 浙江联盛化学股份有限公司 二、监事会会议审议情况 经与会监事认真审议，形成如下决议： (一)审议通过了《关于公司 <2024 年第三季度报告>的议案》 监事会认为：公司 2024 年第三季度报告的编制和审议程序符合相关法律法规及 《公司章程》等内部规章制度的规定；公司 2024 年第三季度报告的内容与格式符合 相关规定，公允地反映了公司 2024 年第三季度报告的财务状况和经营成果等事项， 披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。监事会同 意公司编制的 2024 年第三季度报告。 具体内容详见公司于 2024 年 10 月 30 日在深圳证券交易所网站(www.szse.cn)及 巨潮资讯网(www.cninfo.com.cn)披露的《浙江联盛化学股份有限公司 2024 年第三季 度报告》。 表决结果：同意 3 票、反对 0 票、弃权 0 票。 (二)审议通过了《关于拟使用募集资金向全资子公司增资以实施募投项目的议案》 第三届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有 ...

Revenue and Profit - Revenue for Q3 2024 was CNY 127,592,555.68, an increase of 10.25% compared to the same period last year[3] - Net profit attributable to shareholders was CNY -2,918,513.95, a decrease of 134.41% year-on-year[3] - Net profit excluding non-recurring items was CNY -3,586,108.82, down 167.97% from the previous year[3] - Total operating revenue for the current period is CNY 428,499,956.45, a decrease of 17% compared to CNY 516,164,255.38 in the previous period[15] - Net profit for the current period is CNY 13,588,305.39, a significant decrease of 80% from CNY 68,556,581.24 in the previous period[16] - Basic earnings per share for the current period is CNY 0.13, down from CNY 0.62 in the previous period[17] Assets and Liabilities - Total assets at the end of Q3 2024 were CNY 1,646,791,447.69, a decrease of 2.18% from the end of the previous year[3] - The company’s total equity attributable to shareholders was CNY 1,335,706,335.24, a slight decrease of 0.59% from the previous year[3] - The total current assets decreased from ¥978,386,486.11 to ¥757,240,486.53, reflecting a reduction of about 22.6%[12] - The total non-current assets increased from ¥705,127,186.28 to ¥889,550,961.16, indicating a growth of approximately 26.1%[13] - The total liabilities decreased from ¥307,154,263.63 to ¥278,284,341.10, showing a decline of about 9.4%[13] - The total assets decreased from ¥1,683,513,672.39 to ¥1,646,791,447.69, reflecting a reduction of approximately 2.2%[13] Cash Flow - Cash flow from operating activities was CNY -117,338,044.31, a decline of 172.94% compared to the same period last year[3] - The company reported a significant decrease in net cash flow from operating activities, primarily due to lower revenue and delayed payments from major customers[8] - Cash flow from operating activities shows a net outflow of CNY -117,338,044.31, compared to a net inflow of CNY 160,876,172.24 in the previous period[18] - The net cash flow from investment activities was 118,159,050.68 CNY, compared to a negative cash flow of 86,731,880.10 CNY in the previous period[19] - The net cash flow from financing activities was -16,839,952.43 CNY, improving from -36,533,184.26 CNY in the previous period[19] - The net increase in cash and cash equivalents was -15,140,543.06 CNY, contrasting with an increase of 39,285,580.39 CNY in the previous period[19] Expenses and Investments - Research and development expenses decreased by 33.36% to CNY 14,374,762.66 for the first nine months of 2024[8] - Investment income increased by 292.38% to CNY 1,201,763.33 for the first nine months of 2024[8] - Research and development expenses for the current period are CNY 14,374,762.66, down from CNY 21,569,337.80 in the previous period, indicating a reduction of approximately 33%[15] - The company reported a financial expense of CNY -8,923,220.22, significantly improved from CNY -20,366,499.21 in the previous period[15] Shareholder Information - The total number of common shareholders at the end of the reporting period is 7,965[9] - The company has a total of 57,000,000 shares held by Liansheng Chemical Group, accounting for 52.78% of the total shares[10] - The company has a total of 10,000,000 shares held by Mu Jianyu, representing 9.26% of the total shares[10] Other Financial Information - The company received government subsidies amounting to CNY 80,799.46 in Q3 2024[4] - Cash and cash equivalents at the end of the period totaled 151,152,291.47 CNY, down from 289,948,271.82 CNY at the beginning of the period[19] - The cash inflow from investment activities is CNY 676,367,093.27, a substantial increase compared to CNY 118,200,199.87 in the previous period[18] - The cash outflow for dividend payments and interest was 21,448,345.85 CNY, down from 41,245,341.65 CNY in the previous period[19] - The impact of exchange rate changes on cash and cash equivalents was 878,403.00 CNY, compared to 1,674,472.51 CNY in the previous period[19] - The third quarter report was not audited[19]

证券代码：301212 证券简称：联盛化学 公告编号：2024-033 浙江联盛化学股份有限公司 第三届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 浙江联盛化学股份有限公司（以下简称"公司"）第三届董事会第十五次会议（以 下简称"本次会议"）于 2024 年 10 月 29 日在公司会议室以现场结合通讯的方式召 开。会议通知于 2024 年 10 月 19 日通过专人送出、邮件（电子邮件）或传真等方式 发出，会议应出席董事 8 人，实际出席董事 8 人。本次会议由公司董事长牟建宇女士 召集和主持，公司监事和高级管理人员列席了会议。本次会议的召集、召开及表决程 序符合《中华人民共和国公司法》《中华人民共和国证券法》等有关法律、行政法规、 规范性文件、部门规章及《浙江联盛化学股份有限公司章程》（以下简称《公司章程》） 的相关规定，会议决议合法、有效。 二、董事会会议审议情况 经与会董事认真审议，形成如下决议： （一）审议通过了《关于公司 <2024 年第三季度报告>的议案》 本议案已经第三届董事会审计委员会第 ...

证券代码：301212 证券简称：联盛化学 公告编号：2024-035 浙江联盛化学股份有限公司 关于拟使用募集资金向全资子公司增资以实施 募投项目的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江联盛化学股份有限公司（以下简称"公司"）于 2024 年 10 月 29 日召 开第三届董事会第十五次会议、第三届监事会第十三次会议，审议通过了 关于 拟使用募集资金向全资子公司增资以实施募投项目的议案》，同意公司使用募集 资金人民币 10,000 万元向募投项目"52.6 万吨/年电子和专用化学品改建项目 （一期）"的实施主体联盛化学 （沧州）有限公司 （曾用名：沧州临港北焦化工 有限公司，以下简称 "沧州联盛"）进行增资，本次对沧州联盛的增资金额，由 公司董事会授权董事长或管理层根据该募投项目实施进度情况，分批缴付。 本次增资完成后，沧州联盛的注册资本由 28,050 万元增加至 38,050 万元， 仍为公司全资子公司。本次增资相关事宜不构成关联交易和上市公司重大资产重 组事项。本次增资相关事宜无需公司股东大会审议批准。本次增资相关事宜对公 司的财务 ...

Financial Performance - The company's operating revenue for the first half of 2024 was CNY 300,907,400.77, a decrease of 24.86% compared to CNY 400,438,176.67 in the same period last year[11]. - Net profit attributable to shareholders was CNY 16,441,315.67, down 72.03% from CNY 58,777,008.71 year-on-year[11]. - Basic earnings per share decreased by 72.22%, from CNY 0.54 to CNY 0.15[11]. - The net cash flow from operating activities was CNY -109,031,087.33, a decline of 262.30% compared to CNY 67,179,091.46 in the previous year[11]. - Total assets at the end of the reporting period were CNY 1,655,193,976.38, down 1.68% from CNY 1,683,513,672.39 at the end of the previous year[11]. - The net assets attributable to shareholders decreased by 0.32%, from CNY 1,343,624,141.08 to CNY 1,339,360,836.31[11]. - The weighted average return on net assets was 1.22%, down 3.18% from 4.40% in the previous year[11]. - In Q2 2024, the company reported operating revenue of CNY 166.36 million, a year-on-year decrease of 0.44% but a quarter-on-quarter increase of 23.64%[30]. - The net profit attributable to shareholders in Q2 2024 was CNY 8.44 million, down 66.22% year-on-year but up 5.48% quarter-on-quarter[30]. Industry Trends - The fine chemical industry is experiencing a slow recovery, with a 5.4% year-on-year increase in revenue and a 3.4% increase in operating profit for the chemical raw materials and products manufacturing sector in the first half of 2024[18]. - The global pharmaceutical market is projected to grow from $13.93 trillion in 2021 to $17.11 trillion by 2025, with a compound annual growth rate (CAGR) of 5.3%[20]. - The global pesticide market expanded from $35.575 billion in 2006 to $87.7 billion in 2022, with a CAGR of approximately 5.80%[20]. - The demand for pesticides is anticipated to remain stable due to the increasing global population and the need for food production efficiency[21]. - The fine chemical industry is crucial for the stability and safety of important supply chains, with a focus on innovation and high-quality development in the upcoming years[18]. Company Strategy and Focus - The company is focused on the development of high-end fine chemicals, which is expected to be a key trend in the industry[18]. - The company is recognized as a top 100 high-tech enterprise in fine chemicals and a national-level "specialized, refined, and innovative" small giant enterprise, with a unique industrial chain technology based on BDO[24]. - The company is focusing on green, low-carbon, and digital transformation, emphasizing the development of fine chemicals, electronic chemicals, and biodegradable new materials[24]. - The company aims to upgrade its BDO industrial chain towards ultra-pure electronic chemicals and biodegradable new materials to strengthen its position in the specialty fine chemicals sector[24]. - The company is actively promoting technological innovation and iteration, continuously launching new products and exploring new applications[30]. Financial Management and Investments - The company has made progress in its fundraising projects, with investment completion rates of 83.81% for ultra-pure electronic chemicals and 30.98% for the 52.6 million tons/year electronic and specialty chemicals renovation project[34]. - The total amount of raised funds is RMB 727.03 million, with a net amount after deducting issuance costs of RMB 727.03 million[53]. - The total amount invested from the raised funds during the reporting period is RMB 86.99 million, with a cumulative investment of RMB 407.31 million[54]. - The company has established long-term stable partnerships with renowned companies such as Bayer Group and Syngenta, enhancing its market position[35]. - The company has authorized the use of up to CNY 390 million of temporarily idle raised funds for cash management, with a usage period not exceeding twelve months[57]. Risk Management - The company faces risks including macroeconomic fluctuations, raw material price volatility, and safety production risks[1]. - Future plans and development strategies are subject to risks and should not be considered as firm commitments to investors[1]. - The company is focused on enhancing its core competitiveness through increased R&D efforts to mitigate risks associated with macroeconomic fluctuations[65]. - The company plans to optimize procurement strategies and expand its supplier base to manage risks related to raw material price volatility[66]. - Safety management measures are being strengthened to prevent accidents involving hazardous chemicals, ensuring compliance with safety regulations[67]. Environmental Compliance - The company is committed to reducing environmental impact by improving waste management and adhering to stricter environmental regulations[68]. - The company has established an emergency response plan for environmental incidents, which has been filed with local environmental authorities[83]. - The company has implemented measures to reduce carbon emissions, including steam waste heat utilization and photovoltaic power generation[84]. - The company has established a dedicated EHS department to oversee environmental management and compliance[81]. - The company has implemented strict monitoring of various pollutants, with all online monitoring indicators meeting compliance standards[78]. Shareholder Information - The total number of shares is 108,000,000, with 75% being limited sale condition shares and 25% being unrestricted sale condition shares[110]. - The largest shareholder, Liansheng Chemical Group Co., Ltd., holds 52.78% of the shares, amounting to 57,000,000 shares[110]. - The company has not implemented any share buyback programs during the reporting period[110]. - The report indicates that there are no significant changes in the shareholding structure during the reporting period[110]. - The company distributed a cash dividend of 1.98 yuan per 10 shares, totaling 21.384 million yuan to shareholders for the fiscal year 2023[86]. Compliance and Governance - The financial statements were approved by the board of directors on August 27, 2024, ensuring compliance with accounting standards[150]. - The company has assessed its ability to continue as a going concern for the next 12 months and found no issues affecting this capability[151]. - The company has not engaged in any significant litigation or arbitration matters during the reporting period, indicating a stable legal standing[94]. - The company has not reported any penalties or rectification situations during the reporting period, reflecting compliance with regulations[95]. - The company has not experienced any non-operating fund occupation by major shareholders or related parties during the reporting period, ensuring financial integrity[93].

第三届监事会第十二次会议决议公告 证券代码：301212 证券简称：联盛化学 公告编号：2024-028 浙江联盛化学股份有限公司 表决结果：同意 3 票、反对 0 票、弃权 0 票。 (二)审议通过了《关于公司<2024 年半年度募集资金存放与使用情况的专项报告> 的议案》 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 浙江联盛化学股份有限公司（以下简称"公司"）第三届监事会第十二次会议（以 下简称"本次会议"）于 2024 年 8 月 27 日在公司会议室以现场结合通讯的方式召开。 会议通知于2024年8月17日通过专人送出、邮件（电子邮件）或传真等方式发出。 本次会议应出席监事 3 名，实际出席监事 3 名，本次会议由监事会主席黄卫国先生 主持，保荐机构代表人员列席了会议。本次会议的召集、召开及表决程序符合《中 华人民共和国公司法》《中华人民共和国证券法》等有关法律、行政法规、规范性 文件、部门规章及《浙江联盛化学股份有限公司章程》的相关规定，会议决议合法、 有效。 二、监事会会议审议情况 经与会监事认真审议，形成如下决议： ( ...